It is a once-weekly investigational triple agonist designed to activate three metabolic receptor pathways at the same time: GLP-1, GIP, and glucagon
In the STEP 4 trial, participants who stopped semaglutide regained about two-thirds of the weight they had lost within one year (STEP 4 withdrawal study)
This product may not be appropriate for individuals with certain medical conditions or sensitivities to any of the ingredients included in the formulation
HUBERMAN: Now, this can be a good thing if you're trying to upregulate growth hormone receptors at a given injury site so that growth hormone, which comes from the pituitary, and then we'll talk a bit about more later, then can have a heightened level of action at that tissue and growth hormone is involved in tissue turnover and repair
[29] [30] [31] Thyroid hormones are generally well tolerated
For pregnant or lactating women and children it is recommended to seek medical advice